Chemical synthesis of the 5-taurinomethyl(-2-thio)uridine modified anticodon arm of the human mitochondrial tRNA(Leu(UUR)) and tRNA(Lys).
Identifieur interne : 001D34 ( Main/Merge ); précédent : 001D33; suivant : 001D35Chemical synthesis of the 5-taurinomethyl(-2-thio)uridine modified anticodon arm of the human mitochondrial tRNA(Leu(UUR)) and tRNA(Lys).
Auteurs : Grazyna Leszczynska [Pologne] ; Piotr Leonczak [Pologne] ; Karolina Wozniak [Pologne] ; Andrzej Malkiewicz [Pologne]Source :
- RNA (New York, N.Y.) [ 1469-9001 ] ; 2014.
Descripteurs français
- KwdFr :
- 4-Thiouridine (analogues et dérivés), 4-Thiouridine (synthèse chimique), ARN de transfert de la leucine (génétique), ARN de transfert de la lysine (génétique), Anticodon (génétique), Conformation d'acide nucléique, Humains, Mitochondries (génétique), Mutation (génétique), Oligoribonucléotides (génétique).
- MESH :
- analogues et dérivés : 4-Thiouridine.
- génétique : ARN de transfert de la leucine, ARN de transfert de la lysine, Anticodon, Mitochondries, Mutation, Oligoribonucléotides.
- synthèse chimique : 4-Thiouridine.
- Conformation d'acide nucléique, Humains.
English descriptors
- KwdEn :
- MESH :
- chemical , analogs & derivatives : Thiouridine.
- chemical , chemical synthesis : Thiouridine.
- chemical , genetics : Anticodon, Oligoribonucleotides, RNA, Transfer, Leu, RNA, Transfer, Lys.
- genetics : Mitochondria, Mutation.
- Humans, Nucleic Acid Conformation.
Abstract
5-Taurinomethyluridine (τm(5)U) and 5-taurinomethyl-2-thiouridine (τm(5)s(2)U) are located at the wobble position of human mitochondrial (hmt) tRNA(Leu(UUR)) and tRNA(Lys), respectively. Both hypermodified units restrict decoding of the third codon letter to A and G. Pathogenic mutations in the genes encoding hmt-tRNA(Leu(UUR)) and hmt-tRNA(Lys) are responsible for the loss of the discussed modifications and, as a consequence, for the occurrence of severe mitochondrial dysfunctions (MELAS, MERRF). Synthetic oligoribonucleotides bearing modified nucleosides are a versatile tool for studying mechanisms of genetic message translation and accompanying pathologies at nucleoside resolution. In this paper, we present site-specific chemical incorporation of τm(5)U and τm(5)s(2)U into 17-mers related to the sequence of the anticodon arms hmt-tRNA(Leu(UUR)) and hmt-tRNA(Lys), respectively employing phosphoramidite chemistry on CPG support. Selected protecting groups for the sulfonic acid (4-(tert-butyldiphenylsilanyloxy)-2,2-dimethylbutyl) and the exoamine function (-C(O)CF3) are compatible with the blockage of the canonical monomeric units. The synthesis of τm(5)s(2)U-modified RNA fragment was performed under conditions eliminating the formation of side products of 2-thiocarbonyl group oxidation and/or oxidative desulphurization. The structure of the final oligomers was confirmed by mass spectroscopy and enzymatic cleavage data.
DOI: 10.1261/rna.044412.114
PubMed: 24757169
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001A04
- to stream PubMed, to step Curation: 001A04
- to stream PubMed, to step Checkpoint: 001971
- to stream Ncbi, to step Merge: 000D40
- to stream Ncbi, to step Curation: 000D40
- to stream Ncbi, to step Checkpoint: 000D40
Links to Exploration step
pubmed:24757169Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Chemical synthesis of the 5-taurinomethyl(-2-thio)uridine modified anticodon arm of the human mitochondrial tRNA(Leu(UUR)) and tRNA(Lys).</title>
<author><name sortKey="Leszczynska, Grazyna" sort="Leszczynska, Grazyna" uniqKey="Leszczynska G" first="Grazyna" last="Leszczynska">Grazyna Leszczynska</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz</wicri:regionArea>
<wicri:noRegion>90-924 Lodz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leonczak, Piotr" sort="Leonczak, Piotr" uniqKey="Leonczak P" first="Piotr" last="Leonczak">Piotr Leonczak</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz</wicri:regionArea>
<wicri:noRegion>90-924 Lodz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wozniak, Karolina" sort="Wozniak, Karolina" uniqKey="Wozniak K" first="Karolina" last="Wozniak">Karolina Wozniak</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz</wicri:regionArea>
<wicri:noRegion>90-924 Lodz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Malkiewicz, Andrzej" sort="Malkiewicz, Andrzej" uniqKey="Malkiewicz A" first="Andrzej" last="Malkiewicz">Andrzej Malkiewicz</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz</wicri:regionArea>
<wicri:noRegion>90-924 Lodz</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24757169</idno>
<idno type="pmid">24757169</idno>
<idno type="doi">10.1261/rna.044412.114</idno>
<idno type="wicri:Area/PubMed/Corpus">001A04</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A04</idno>
<idno type="wicri:Area/PubMed/Curation">001A04</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A04</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001971</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001971</idno>
<idno type="wicri:Area/Ncbi/Merge">000D40</idno>
<idno type="wicri:Area/Ncbi/Curation">000D40</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D40</idno>
<idno type="wicri:Area/Main/Merge">001D34</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Chemical synthesis of the 5-taurinomethyl(-2-thio)uridine modified anticodon arm of the human mitochondrial tRNA(Leu(UUR)) and tRNA(Lys).</title>
<author><name sortKey="Leszczynska, Grazyna" sort="Leszczynska, Grazyna" uniqKey="Leszczynska G" first="Grazyna" last="Leszczynska">Grazyna Leszczynska</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz</wicri:regionArea>
<wicri:noRegion>90-924 Lodz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leonczak, Piotr" sort="Leonczak, Piotr" uniqKey="Leonczak P" first="Piotr" last="Leonczak">Piotr Leonczak</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz</wicri:regionArea>
<wicri:noRegion>90-924 Lodz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wozniak, Karolina" sort="Wozniak, Karolina" uniqKey="Wozniak K" first="Karolina" last="Wozniak">Karolina Wozniak</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz</wicri:regionArea>
<wicri:noRegion>90-924 Lodz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Malkiewicz, Andrzej" sort="Malkiewicz, Andrzej" uniqKey="Malkiewicz A" first="Andrzej" last="Malkiewicz">Andrzej Malkiewicz</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz</wicri:regionArea>
<wicri:noRegion>90-924 Lodz</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">RNA (New York, N.Y.)</title>
<idno type="eISSN">1469-9001</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anticodon (genetics)</term>
<term>Humans</term>
<term>Mitochondria (genetics)</term>
<term>Mutation (genetics)</term>
<term>Nucleic Acid Conformation</term>
<term>Oligoribonucleotides (genetics)</term>
<term>RNA, Transfer, Leu (genetics)</term>
<term>RNA, Transfer, Lys (genetics)</term>
<term>Thiouridine (analogs & derivatives)</term>
<term>Thiouridine (chemical synthesis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>4-Thiouridine (analogues et dérivés)</term>
<term>4-Thiouridine (synthèse chimique)</term>
<term>ARN de transfert de la leucine (génétique)</term>
<term>ARN de transfert de la lysine (génétique)</term>
<term>Anticodon (génétique)</term>
<term>Conformation d'acide nucléique</term>
<term>Humains</term>
<term>Mitochondries (génétique)</term>
<term>Mutation (génétique)</term>
<term>Oligoribonucléotides (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Thiouridine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Thiouridine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Anticodon</term>
<term>Oligoribonucleotides</term>
<term>RNA, Transfer, Leu</term>
<term>RNA, Transfer, Lys</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>4-Thiouridine</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Mitochondria</term>
<term>Mutation</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>ARN de transfert de la leucine</term>
<term>ARN de transfert de la lysine</term>
<term>Anticodon</term>
<term>Mitochondries</term>
<term>Mutation</term>
<term>Oligoribonucléotides</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>4-Thiouridine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Nucleic Acid Conformation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Conformation d'acide nucléique</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">5-Taurinomethyluridine (τm(5)U) and 5-taurinomethyl-2-thiouridine (τm(5)s(2)U) are located at the wobble position of human mitochondrial (hmt) tRNA(Leu(UUR)) and tRNA(Lys), respectively. Both hypermodified units restrict decoding of the third codon letter to A and G. Pathogenic mutations in the genes encoding hmt-tRNA(Leu(UUR)) and hmt-tRNA(Lys) are responsible for the loss of the discussed modifications and, as a consequence, for the occurrence of severe mitochondrial dysfunctions (MELAS, MERRF). Synthetic oligoribonucleotides bearing modified nucleosides are a versatile tool for studying mechanisms of genetic message translation and accompanying pathologies at nucleoside resolution. In this paper, we present site-specific chemical incorporation of τm(5)U and τm(5)s(2)U into 17-mers related to the sequence of the anticodon arms hmt-tRNA(Leu(UUR)) and hmt-tRNA(Lys), respectively employing phosphoramidite chemistry on CPG support. Selected protecting groups for the sulfonic acid (4-(tert-butyldiphenylsilanyloxy)-2,2-dimethylbutyl) and the exoamine function (-C(O)CF3) are compatible with the blockage of the canonical monomeric units. The synthesis of τm(5)s(2)U-modified RNA fragment was performed under conditions eliminating the formation of side products of 2-thiocarbonyl group oxidation and/or oxidative desulphurization. The structure of the final oligomers was confirmed by mass spectroscopy and enzymatic cleavage data. </div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D34 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001D34 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Merge |type= RBID |clé= pubmed:24757169 |texte= Chemical synthesis of the 5-taurinomethyl(-2-thio)uridine modified anticodon arm of the human mitochondrial tRNA(Leu(UUR)) and tRNA(Lys). }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:24757169" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |